Skip to main content
. Author manuscript; available in PMC: 2015 Jun 1.
Published in final edited form as: Cancer Chemother Pharmacol. 2014 Apr 24;73(6):1137–1146. doi: 10.1007/s00280-014-2447-3

Table 2.

Summary of pharmacokinetic estimates for EF-24 following administration of a 10 mg/kg dose.

Intravenous Oral Intraperitoneal
Tmax, min 2.7 3 3
Cmax, nM 2494 882 833
t1/2α, min 0.4 3.3 8.9
t1/2β, min 5.4 -- --
t1/2z, min 73.6 177 219
AUC, nM•min 59730 35914 20734
C1p, L/min/kg 0.482
Vss, L/kg 4.85
Bioavailability - 60.1% 34.7%